# A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL

> **NCT00774332** · PHASE2 · UNKNOWN · sponsor: **Cooperative Study Group A for Hematology** · enrollment: 37 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** CODOX-M

## Key facts

- **NCT ID:** NCT00774332
- **Lead sponsor:** Cooperative Study Group A for Hematology
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-06
- **Primary completion:** 2006-06
- **Final completion:** 2009-12
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2008-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774332, "A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00774332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*